Advanced Viral Research Corp.

Sixteenth patent granted to biopharmaceutical firm

Published in Medicine and Law Weekly, June 17th, 2005

Advanced Viral Research Corp. (ADVR) announced that the patent office in Mexico has granted the company patent #225306 entitled "Preparation of a Therapeutic Composition" for AVR118.

The patent describes the composition of AVR118 and methods of manufacturing it.

"We continue to safeguard versatile applications for AVR118 and strengthen our intellectual property position," said Elma S. Hawkins, president and CEO of Advanced Viral Research Corp. "This patent increases ADVR's growing intellectual property position, which now includes 16 patents."

Currently, ADVR is engaged in a phase II, multicenter, randomized, double-blind United...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medicine and Law Weekly

Source: Medicine and Law Weekly (2005-06-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry